Ajanal Manjunath, Prasad B S
Department of Dravyaguna and Medical Research Center, Rajiv Gandhi Education Society's Ayurveda Medical College and PG Research Centre, Ron, India.
Department of Panchakarma, KLEU Shri BMK Ayurved Mahavidhyalaya, Belgaum, Karnataka, India.
Anc Sci Life. 2014 Jan;33(3):172-5. doi: 10.4103/0257-7941.144622.
It is a common notion among people in India that herbal or Ayurvedic products are safe and do not produce any adverse effect. This is not true since Ayurveda has evaded many adverse effects which occur by combination of herbs. This axiom is potentiated by our report that occurs in the form of skin rashes. A 20-year-old South Indian female of Pittakapha prakṛti (constitution) after beginning therapy with Aragvādādi kaṣāyam (ARK) (poly-herbal formulation) and Syrup Talekt (poly-herbal patent formulation) for the treatment of recurrent incidence of abscess. Rash disappeared after stopping the suspected drug and treatment with Vibhītakī kaṣāyam (decoction of Terminilia bellarica) and Śatadhauta ghṛtam. Possible and probable (score 6) were the causality according to WHO-Uppsala Monitoring Centre and Naranjo's Adverse Drug Reaction Probability Scale and grouped under type-B reaction. To the best of our knowledge, this is the first case of skin rashes which seen after administration of ARK and Syrup Talekt. This report highlights the need of implementation of pharmacovigilance center in the hospital level and additional research in the field of skin toxicity of ARK and Syrup Talekt.
在印度民众中普遍存在一种观念,即草药或阿育吠陀产品是安全的,不会产生任何不良反应。但这并不正确,因为阿育吠陀疗法规避了许多因草药组合而产生的不良反应。我们这份以皮疹形式出现的报告强化了这一观点。一名20岁的南印度女性,体质为皮塔卡法,在开始使用阿拉格瓦达迪卡沙亚姆(ARK)(多草药配方)和糖浆塔利克(多草药专利配方)治疗反复出现的脓肿后,出现了皮疹。停用可疑药物并用毗醯勒伽卡沙亚姆(毗黎勒煎剂)和百次净化酥油治疗后,皮疹消失。根据世界卫生组织-乌普萨拉监测中心和纳兰霍药物不良反应概率量表,因果关系为可能和很可能(评分为6),并归类为B型反应。据我们所知,这是首次报告在使用ARK和糖浆塔利克后出现皮疹的病例。本报告强调了在医院层面设立药物警戒中心的必要性,以及对ARK和糖浆塔利克皮肤毒性领域进行更多研究的必要性。